Report period | 2018 | 2019 | 2020 | 2021 | 2022 | Q3 23 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, $ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
GDRX:US | GoodRx Holdings | Common share | - | US38246G1085 | $5.04 |
Company name | GoodRx Holdings |
---|---|
Tags | #software |
Sector | Information Technology / Software & Services / IT Services / Internet Services & Infrastructure |
Business address | 233 Wilshire Blvd Suite 990 Santa Monica, CA 90401 United States |
Website | investors.goodrx.com |
Information disclosure | www.sec.gov |